The filing clears the regulatory path for potential first-in-human trials and marks a key advance in the company’s chronic inflammatory disease pipeline
More than five drug candidates from his team progressed to human trials including drugs like Rilematovir (Phase IIb), and Bedaquiline
Wockhardt plans to launch Miqnaf in the Indian market in coming few months
The company expects that this development could improve the strength of its application to the FDA for new drug approval
Seamless transition from preclinical to first-in-human trials with EUDRACAP platform technology
Envelta is the company’s non-opioid pain product candidate for acute and chronic pain
Complaints to be filed in both United States and Germany alleging that Pfizer and BioNTech's COVID-19 vaccine Comirnaty unlawfully infringes patents Moderna filed between 2010 and 2016
BVX-0922 to target colorectal cancer under investigator-sponsored IND
Funding will support continued advancement of Centauri’s antimicrobial resistance research to identify novel therapeutic candidates using its proprietary Alphamer platform
Subscribe To Our Newsletter & Stay Updated
